DOMO, INC.

Securities Trading Plans of Directors and Officers

During our last fiscal quarter, no director or officer, as defined in Rule 16a-1(f), adopted orterminated a “Rule 10b5-1 trading arrangement” or a “non-Rule 10b5-1 trading arrangement,” each as defined in Item 408 of Regulation S-K.

Appointment of Principal Executive Officer

As previously disclosed in the Company’s Current Report on Form 8-K filed with the SEC on December 5, 2025, in December 2025, the Company appointed Daren Thayne, the Company’s Chief Technology Officer and Executive Vice President of Product as the Company’s Interim Principal Executive Officer. Mr. Thayne remains the Company’s Chief Technology Officer and Executive Vice President of Product and the Company has reappointed Joshua G. James, the Company’s Chief Executive Officer and member of the Board of Directors as the Company’s Principal Executive Officer (within the meaning of the rules and regulations of the Securities Exchange Act of 1934, as amended), effective April 15, 2026. For Mr. James’ biographical information, see the disclosure included under the heading “Executive Officers” in the Company’s definitive proxy statement for the 2025 annual meeting of stockholders filed with the SEC on May 13, 2025 (the "2025 Proxy").

Mr. James is continuing under the terms of his existing compensation arrangements with the Company. There are no family relationships between Mr. James and any director or executive officer of the Company that require disclosure under Item 401(d) of Regulation S-K. The information required by Item 404(a) of Regulation S-K with respect to Mr. James is incorporated herein by reference to the information set forth under the heading "Related Party Transactions" in the Company's 2025 Proxy. Furthermore, there are no arrangements or understandings between Mr. James and any other persons pursuant to which Mr. James was selected as the Principal Executive Officer of the Company.

Change in Control and Severance Agreement

On April 15, 2026, the Company and Tod Crane, the Company's Chief Financial Officer, entered into the Company's standard Change in Control and Severance Agreement, in substantially the form previously approved by the Board and filed as Exhibit 10.11 hereto, which is incorporated herein by reference. Pursuant to this agreement, Mr. Crane is entitled to receive certain change in control and severance benefits, including:

•If the Company terminates Mr. Crane’s employment other than for “cause,” death or disability, or Mr. Crane resigns for “good reason”, then, subject to delivery and execution of a customary release and separation agreement in favor of the Company, Mr. Crane will be eligible to receive:

◦a lump-sum payment equal to 12 months of Mr. Crane's annual base salary as in effect immediately prior to such termination (or if such termination is due to a resignation for good reason based on a material reduction in base salary, then as in effect immediately prior to the reduction);

◦a lump-sum payment equal to 100% of Mr. Crane’s target annual bonus as in effect for the fiscal year in which such termination occurs; and

◦payment of premiums for coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended (“COBRA”) for him and his eligible dependents, if any, for up to 12 months, or taxable monthly payments for the equivalent period if payment of the COBRA premiums would violate or be subject to an excise tax under applicable law.

•Additionally, if such termination or resignation occurs during the period beginning 60 days before a change in control and ending 12 months following a change in control, then, subject to the same conditions set forth above, Mr. Crane will also be eligible to receive:

◦100% accelerated vesting and exercisability of all outstanding equity awards and, in the case of an equity award with performance-based vesting, all performance goals and other vesting criteria generally will be deemed achieved at 100% of target levels.